XML 44 R29.htm IDEA: XBRL DOCUMENT v3.25.1
Organization and Basis of Presentation (Tables)
 3 Months Ended
Mar. 31, 2025
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Schedule of Components of Marketable Securities
As of March 31, 2025 and December 31, 2024, marketable securities consisted of the following ($ in thousands):
 March 31, 2025
 Amortized CostGross
Unrealized Gain (Loss)		Carrying Value
Equity securities:
Investment funds - debt securities$2,676 $(22)$2,654 
Common stock, preferred stock and stock funds49,247 17,881 67,128 
Debt securities:
Available for sale
U.S. treasury securities3,125 12 3,137 
Corporate debt securities3,089 5 3,094 
Total - Marketable securities $58,137 $17,876 $76,013 

 December 31, 2024
 Amortized CostGross
Unrealized Gain (Loss)		Carrying Value
Equity securities:
Investment funds - debt securities$2,645 $(67)$2,578 
Common stock, preferred stock and stock funds49,195 18,021 67,216 
Total - Marketable securities $51,840 $17,954 $69,794 
Schedule of Changes in Accumulated Other Comprehensive Income, Net by Component
Changes in Accumulated Other Comprehensive Income, Net by Component

Essex Property Trust, Inc.
($ in thousands):
 Change in fair
value and amortization
of swap settlements		Unrealized
gain on
available for sale debt securities		Total
Balance at December 31, 2024$24,655 $— $24,655 
Other comprehensive loss before reclassification(9,053)16 (9,037)
Amounts reclassified from accumulated other comprehensive income 2 — 2 
Other comprehensive loss(9,051)16 (9,035)
Balance at March 31, 2025$15,604 $16 $15,620 

Essex Portfolio, L.P.
($ in thousands):
 Change in fair
value and amortization
of swap settlements		Unrealized
gain on
available for sale debt securities		Total
Balance at December 31, 2024$29,429 $— $29,429 
Other comprehensive loss before reclassification(9,374)17 (9,357)
Amounts reclassified from accumulated other comprehensive income2 — 2 
Other comprehensive loss(9,372)17 (9,355)
Balance at March 31, 2025$20,057 $17 $20,074 
Schedule of Changes to the Redemption Value of Noncontrolling Interests
The changes in the redemption value of redeemable noncontrolling interests for the three months ended March 31, 2025 is as follows ($ in thousands):
Balance at December 31, 2024$30,849 
Reclassification due to change in redemption value and other3,527 
Balance at March 31, 2025$34,376 
Schedule of Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows ($ in thousands):
 March 31, 2025December 31, 2024March 31, 2024December 31, 2023
Cash and cash equivalents - unrestricted$98,735 $66,795 $499,036 $391,749 
Cash and cash equivalents - restricted9,127 9,051 8,834 8,585 
Total unrestricted and restricted cash and cash equivalents shown in the condensed consolidated statements of cash flows$107,862 $75,846 $507,870 $400,334 
Schedule of Restricted Cash and Cash Equivalents
The following table provides a reconciliation of cash, cash equivalents, and restricted cash reported within the condensed consolidated balance sheets that sum to the total of the same such amounts shown in the condensed consolidated statements of cash flows ($ in thousands):
 March 31, 2025December 31, 2024March 31, 2024December 31, 2023
Cash and cash equivalents - unrestricted$98,735 $66,795 $499,036 $391,749 
Cash and cash equivalents - restricted9,127 9,051 8,834 8,585 
Total unrestricted and restricted cash and cash equivalents shown in the condensed consolidated statements of cash flows$107,862 $75,846 $507,870 $400,334